Phase 1b ADVENT-AML trial of CHM CORE-NK advances at MDA

About this update from Chimeric Therapeutics Limited

Chimeric Therapeutics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Chimeric Therapeutics Limited